DOI QR코드

DOI QR Code

Tumor Necrosis Factor ${\alpha}$ up-regulates the Expression of beta2 Adrenergic Receptor via NF-${\kappa}B$-dependent Pathway in Osteoblasts

  • Baek, Kyunghwa (Department of Pharmacology, College of Dentistry, Research Institute of Oral Biology, Gangneung-Wonju National University) ;
  • Kang, Jiho (Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Hwang, Hyo Rin (Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Baek, Jeong-Hwa (Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University)
  • Received : 2013.07.16
  • Accepted : 2013.08.07
  • Published : 2013.09.30

Abstract

Tumor necrosis factor alpha ($TNF{\alpha}$) is a multifunctional inflammatory cytokine that regulates various cellular and biological processes. Increased levels of $TNF{\alpha}$ have been implicated in a number of human diseases including diabetes and arthritis. Sympathetic nervous system stimulation via the beta2-adrenergic receptor (${\beta}2AR$) in osteoblasts suppresses osteogenic activity. We previously reported that $TNF{\alpha}$ upregulates ${\beta}2AR$ expression in murine osteoblastic cells and that this modulation is associated with $TNF{\alpha}$ inhibition of osteoblast differentiation. In our present study, we explored whether $TNF{\alpha}$ induces ${\beta}2AR$ expression in human osteoblasts and then identified the downstream signaling pathway. Our results indicated that ${\beta}2AR$ expression was increased in Saos-2 and C2C12 cells by $TNF{\alpha}$ treatment, and that this increase was blocked by the inhibition of NF-${\kappa}B$ activation. Chromatin immunoprecipitation and luciferase reporter assay results indicated that NF-${\kappa}B$ directly binds to its cognate elements on the ${\beta}2AR$ promoter and thereby stimulates ${\beta}2AR$ expression. These findings suggest that the activation of $TNF{\alpha}$ signaling in osteoblastic cells leads to an upregulation of ${\beta}2AR$ and also that $TNF{\alpha}$ induces ${\beta}2AR$ expression in an NF-${\kappa}B$-dependent manner.

Keywords

References

  1. Togari A, Arai M. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci. 2008;106:542-546. https://doi.org/10.1254/jphs.FM0070227
  2. Feve B, Emorine LJ, Lasnier F, Blin N, Baude B, Nahmias C, Strosberg AD, Pairault J. Atypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor. J Biol Chem. 1991;266:20329-20336.
  3. El Hadri K, Feve B, Pairault J. Developmental expression and functional activity of beta 1- and beta 3-adrenoceptors in murine 3T3-F442A differentiating adipocytes. Eur J Pharmacol. 1996;297:107-119. https://doi.org/10.1016/0014-2999(95)00723-7
  4. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell. 2005;122:803-815. https://doi.org/10.1016/j.cell.2005.06.028
  5. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005;434:514-520. https://doi.org/10.1038/nature03398
  6. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002;111:305-317. https://doi.org/10.1016/S0092-8674(02)01049-8
  7. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med. 1997;185:1573-1584. https://doi.org/10.1084/jem.185.9.1573
  8. Maini RN. The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995. J R Coll Physicians Lond. 1996;30:344-351.
  9. Navarro-Gonzalez JF, Jarque A, Muros M, Mora C, Garcia J. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev. 2009;20:165-173. https://doi.org/10.1016/j.cytogfr.2009.02.005
  10. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165-176. https://doi.org/10.1016/S0092-8674(00)81569-X
  11. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem. 2001;276:563-568.
  12. Kwon YM, Kim SW, Ko SY. Effects of Interleukin-$1{\beta}$, tumor necrosis factor-2 and interferon-${\gamma}$ on the nitric oxide production and osteoclast generation in the culture of mouse bone marrow cells. Int J Oral Biol. 2006;31:67-72.
  13. McMahon MS, Ueki Y. Does anti-TNF-alpha have a role in the treatment of osteoporosis? Bull NYU Hosp Jt Dis. 2008;66:280-281.
  14. Lee HL, Yi T, Woo KM, Ryoo HM, Kim GS, Baek JH. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med. 2010;42:437-445. https://doi.org/10.3858/emm.2010.42.6.045
  15. Baek K, Lee HL, Hwang HR, Park HJ, Kwon AR, Qadir A, Baek JH. $TNF{\alpha}$ increases the expression of ${\beta}2$ adrenergic receptors in osteoblasts. Int J Oral Biol. 2011;36:173-178.
  16. Baek K, Cho JY, Hwang HR, Kwon A, Lee HL, Park HJ, Qadir AS, Ryoo HM, Woo KM, Baek JH. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor gamma expression in bone marrow. J Cell Physiol. 2012;227:3603-3612. https://doi.org/10.1002/jcp.24064
  17. Szentendrei T, Lazar-Wesley E, Nakane T, Virmani M, Kunos G. Selective regulation of beta 2-adrenergic receptor gene expression by interleukin-1 in cultured human lung tumor cells. J Cell Physiol. 1992;152:478-485. https://doi.org/10.1002/jcp.1041520306
  18. Guo M, Pascual RM, Wang S, Fontana MF, Valancius CA, Panettieri RA, Jr., Tilley SL, Penn RB. Cytokines regulate beta-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. Biochemistry. 2005;44:13771-13782. https://doi.org/10.1021/bi051255y